Swipe tables sideways to see all columns.
Research findings
Comparative structure study
The largest recorded reporting jurisdiction, Jiangsu, contains 7 records (21.2% of this 33-record cohort). The remaining cohort contains 26 records. The comparison concerns archive composition.
The recorded industry label Biomedicine accounts for 69.7% here (23/33), compared with 8.9% in the parent set (1,721/19,297), an absolute gap of 60.8 percentage points.
16/33 companies link to pages with existing source-supported excerpts (48.5% of the cohort). The other 17 records remain usable for archive composition, but do not support new operating case studies.
11 keyword candidates match only a company name, with no matching term in recorded products or sub-industry fields. Product evidence is needed before treating these as operating businesses in this segment.
| Company cohort | Directly linked pages | Share of public archive | Archive date |
|---|---|---|---|
| 33 | 33 | 0.2% | 2026-10-16 |
An ID-deduplicated archive snapshot, not the whole market, current recognition or operating results.
Comparable sets and compositional differences
The parent set, All public archive records, contains 19,297 records. This cohort contributes 33 (0.2%); 19,264 records remain after excluding it.
| Category | Cohort count/base | Reference: All public archive records | Gap (pp) | Representation ratio | Rest count/base |
|---|---|---|---|---|---|
| industry · Biomedicine | 23/33 · 69.7% | 1,721/19,297 · 8.9% | +60.8 | 7.81 | 1,698/19,264 |
| chain role · Biomedicine and medical devices / Complete systems and use-case applications | 16/33 · 48.5% | 1,373/19,297 · 7.1% | +41.4 | 6.81 | 1,357/19,264 |
| sub-industry · Chemical drugs and formulations | 11/33 · 33.3% | 143/19,297 · 0.7% | +32.6 | 44.98 | 132/19,264 |
| sub-industry · Biomedicine | 7/33 · 21.2% | 699/19,297 · 3.6% | +17.6 | 5.86 | 692/19,264 |
| chain role · Biomedicine and medical devices / Process equipment and inspection instruments | 5/33 · 15.2% | 12/19,297 · 0.1% | +15.1 | 243.65 | 7/19,264 |
| industry · Advanced equipment | 5/33 · 15.2% | 4,918/19,297 · 25.5% | -10.3 | 0.59 | 4,913/19,264 |
| reporting jurisdiction · Jiangsu | 7/33 · 21.2% | 3,025/19,297 · 15.7% | +5.5 | 1.35 | 3,018/19,264 |
| chain role · Advanced equipment and industrial automation / Process equipment and inspection instruments | 7/33 · 21.2% | 4,085/19,297 · 21.2% | +0.0 | 1.00 | 4,078/19,264 |
Ratio of label participation, not market share; multi-label counts overlap.
Excluding this cohort, the recorded industry label Biomedicine covers 1,698/19,264 remaining records (8.8%), an absolute gap of 60.9 percentage points from this cohort.
Concentration and cross-sectional structure
The full reporting jurisdiction distribution has 19 labels; the top 3 contain 12/33 records (36.4%).Other known labels contain 21 records.
For 33 records with known labels, the effective category count is 11.7, versus 19 actual labels. Definitions and scope are in the methodology.
The table shows ten labels; 9 others are included in the calculations above.
| Recorded label | Records | Share of cohort |
|---|---|---|
| Jiangsu | 7 | 21.2% |
| Liaoning | 3 | 9.1% |
| Anhui | 2 | 6.1% |
| Shandong | 2 | 6.1% |
| Henan | 2 | 6.1% |
| Zhejiang | 2 | 6.1% |
| Hubei | 2 | 6.1% |
| Chongqing | 2 | 6.1% |
| Shanghai | 1 | 3.0% |
| Yunnan | 1 | 3.0% |
Record counts do not rank supply capability or economic size.
The largest intersection, Jiangsu × Biomedicine, contains 5 records, or 71.4% of the 7 records carrying the Jiangsu label.
| reporting jurisdiction | industry | Intersection records | Cohort share |
|---|---|---|---|
| Jiangsu | Biomedicine | 5 | 15.2% |
| Anhui | Biomedicine | 2 | 6.1% |
| Hubei | Biomedicine | 2 | 6.1% |
| Chongqing | Biomedicine | 2 | 6.1% |
| Shanghai | Biomedicine | 1 | 3.0% |
| Yunnan | Biomedicine | 1 | 3.0% |
| Jilin | Biomedicine | 1 | 3.0% |
| Sichuan | Light industry and textiles | 1 | 3.0% |
A cell contains company IDs carrying both labels. It does not establish procurement, supply or investment relationships between firms. Multi-label cells may overlap.
This page displays 8 of the full cross-tab’s 26 non-empty cells; the other 18 remain in the analysis.
Evidence coverage and strength of conclusions
| Record field | Non-empty/cohort | Completion |
|---|---|---|
| Company name | 33/33 | 100.0% |
| reporting jurisdiction | 33/33 | 100.0% |
| industry | 33/33 | 100.0% |
| Recorded products | 33/33 | 100.0% |
| sub-industry | 33/33 | 100.0% |
| Chain labels | 33/33 | 100.0% |
Non-empty fields are not necessarily accurate or supported by originals.
| Scope of source support | Count |
|---|---|
| Profiles with source-supported excerpts | 16 |
| Distinct corresponding companies | 16 |
| Reviewed Chinese/English paragraph pairs | 16 |
Counts concern existing reviewed bilingual excerpts, not re-certification of originals or entire reports.
| Transparent rule reminder | Records | Cohort share |
|---|---|---|
| Only generic operations vocabulary remains | 1 | 3.0% |
A rule hit prioritises review; it does not establish that the entire field is wrong. One record can trigger several rules.
| Matched field | Candidates | Cohort share |
|---|---|---|
| Company name | 12 | 36.4% |
| Recorded products | 20 | 60.6% |
| Sub-industry | 2 | 6.1% |
An ID may match several fields, so counts may exceed the cohort total. Matches establish search relevance only.
Among the translated non-broad query terms, “capsules” has the most matches: 14/33. Name, product and sub-industry fields match 1, 14 and 0 records respectively; the largest field is product field. Fields can overlap, and a term remains a search link rather than verified business activity.
| Selected query term | Candidates/share | Name matches | Product field | Sub-industry |
|---|---|---|---|---|
| capsules | 14 · 42.4% | 1 | 14 | 0 |
Selected broad terms and specific segment terms, not the full query. Terms and fields can overlap and must not be summed. Counts show lexical sensitivity; no records are removed without primary evidence.
11 candidates match only a name, or lose all product-field matches after the full company name is removed while sub-industry also has no hit. This transparent string test locates copied company descriptions; it does not establish that a company does not operate the business.
Intersection with 2026 local lists
5 of this cohort’s 33 records link through existing company-ID mappings to 2026 lists from all jurisdictions (15.2%). This intersection measures list linkage, not successful recognition or company growth.
| Observation set | List records | New-applicant records | Review records | Mapped company IDs |
|---|---|---|---|---|
| National list records linked to this cohort’s IDs | 5 | 1 | 4 | 5 |
List rows and company IDs are separate counts, not new firms or final recognition.
Stored 2026 local-recommendation records, sources and stage definitionsRecorded roles and delivery checks
Drug-production leads need validation and change records
The Chemical drugs and formulations label covers 11 records (33.3% of this cohort). This archive clue raises a verification question about Defined pharmaceutical-production or testing services with quality documents; it does not establish that these companies already deliver it.
Delivery framework, stages and original sourcesRelated studies and shared records
Shared records with Pharmaceutical Tablet Capsule Equipment Keyword Candidate Study: 13; records in this cohort but outside that set: 20. The intersection/union ratio is 38.2%, a measure of label overlap rather than business collaboration. Read comparison
Shared records with Pharmaceutical Equipment Cleanroom Keyword Candidate Study: 15; records in this cohort but outside that set: 18. The intersection/union ratio is 37.5%, a measure of label overlap rather than business collaboration. Read comparison
Company samples and record links
| Company | Jurisdiction | Recorded industry |
|---|---|---|
| Yichun Wonsen Intelligent Equipment Co., Ltd. | Jiangxi | Biomedicine |
| Anhui Zhanghengchun Pharmaceutical Co., Ltd. | Anhui | Biomedicine |
| Taiji Group Chongqing Tongjunge Pharmaceutical Co., Ltd. | Chongqing | Biomedicine |
| Chongqing Fuling Sanhai Lanling Co., Ltd. | Chongqing | Biomedicine |
| ShanxiTongda Pharmaceutical Co., Ltd. | Shanxi | Biomedicine |
| Changzhou HUAJIAN Pharm Pack Material Co., Ltd. | Jiangsu | Advanced materials |
| Liaoning Tianyi Machinery Co., Ltd. | Liaoning | Advanced equipment |
| Yunnan Leiyunshang Pharmaceutical Co., Ltd. | Yunnan | Biomedicine |
Stable-ID samples, not rankings; metrics use the full cohort.
Directly related profiles and reports
| Page | Presentation |
|---|---|
| Yichun Wonsen Intelligent Equipment Co., Ltd. | Company data profile |
| Anhui Zhanghengchun Pharmaceutical Co., Ltd. | Company data profile |
| Taiji Group Chongqing Tongjunge Pharmaceutical Co., Ltd. | Company report page |
| Chongqing Fuling Sanhai Lanling Co., Ltd. | Company data profile |
| ShanxiTongda Pharmaceutical Co., Ltd. | Company data profile |
| Changzhou HUAJIAN Pharm Pack Material Co., Ltd. | Company data profile |